ID: ALA5094433

Max Phase: Preclinical

Molecular Formula: C17H21Cl2NO2

Molecular Weight: 342.27

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc(Cl)cc1Cl)N(O)CCCCCC1CC1

Standard InChI:  InChI=1S/C17H21Cl2NO2/c18-15-9-7-14(16(19)12-15)8-10-17(21)20(22)11-3-1-2-4-13-5-6-13/h7-10,12-13,22H,1-6,11H2/b10-8+

Standard InChI Key:  XECRERJBAWZBKY-CSKARUKUSA-N

Associated Targets(non-human)

Botulinum neurotoxin type A 1303 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 342.27Molecular Weight (Monoisotopic): 341.0949AlogP: 5.19#Rotatable Bonds: 8
Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.78CX Basic pKa: CX LogP: 5.24CX LogD: 5.22
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.31Np Likeness Score: -0.30

References

1. Patel EN, Turner LD, Hixon MS, Janda KD..  (2022)  Identification of Slow-Binding Inhibitors of the BoNT/A Protease.,  13  (4.0): [PMID:35450355] [10.1021/acsmedchemlett.2c00028]

Source